Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Birch

Showing results (151-160 of 153) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 153 results.
The British Journal of Dermatology|February 8, 2012
Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair lossS Redler, F F Brockschmidt, R Tazi-Ahnini, et al.
The British Journal of Dermatology|December 19, 2013
The oestrogen receptor 2 (ESR2) gene in female-pattern hair loss: replication of association with rs10137185 in German patientsS Redler, P Birch, D Drichel, et al.
BJUI Compass|October 21, 2022
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testingEoin Dinneen, Gregory L Shaw, Roseann Kealy, et al.
Pageof 16

Showing results (151-160 of 153) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 153 results.
The British Journal of Dermatology|February 8, 2012
Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair lossS Redler, F F Brockschmidt, R Tazi-Ahnini, et al.
The British Journal of Dermatology|December 19, 2013
The oestrogen receptor 2 (ESR2) gene in female-pattern hair loss: replication of association with rs10137185 in German patientsS Redler, P Birch, D Drichel, et al.
BJUI Compass|October 21, 2022
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testingEoin Dinneen, Gregory L Shaw, Roseann Kealy, et al.
Pageof 16